- Record: found
- Abstract: not found
- Article: not found
Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar
Sarah J Gutman
1
,
2
,
3 ,
Benedict T Costello
1
,
2
,
3 ,
Stavroula Papapostolou
1
,
3 ,
Aleksandr Voskoboinik
1
,
2
,
4
,
5 ,
Leah Iles
1
,
2 ,
Johnson Ja
1 ,
James L Hare
1
,
2 ,
Andris Ellims
1 ,
Peter M Kistler
1
,
2
,
3
,
5 ,
Thomas H Marwick
1
,
2
,
3 ,
Andrew J Taylor
1
,
2
,
3
August 10 2018
August 10 2018
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
In patients with non-ischaemic cardiomyopathy (NICM), the mortality benefit of a primary
prevention implantable cardioverter-defibrillator (ICD) has been challenged. Left
ventricular (LV) scar identified by cardiac magnetic resonance (CMR) imaging is associated
with a high risk of malignant arrhythmia in NICM. We aimed to determine the impact
of LV scar on the mortality benefit from a primary prevention ICD in NICM.